|
|
|
|
| LEADER |
01031nam a2200229 a 4500 |
| 001 |
727077 |
| 005 |
20171111231103.0 |
| 008 |
991023s1996 gr r 000 0 eng d |
| 020 |
|
|
|a 9283212673
|
| 040 |
|
|
|a GR-KoDPT
|b gre
|e AACR2
|
| 110 |
2 |
|
|a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans
|
| 245 |
1 |
0 |
|a Human immunodeficiency viruses and human T-cell lymphotropic viruses
|
| 260 |
|
|
|a Lyon:
|b International Agency for Research on Cancer, World Health Organization,
|c 1996
|
| 300 |
|
|
|a xii, 424 σ. :
|b εικ. ;
|c 25 εκ.
|
| 490 |
0 |
|
|a IARC monographs on the evaluation of carcinogenic risks to humans
|v v. 67
|x 0250-9555
|
| 504 |
|
|
|a Περιέχει βιβλιογραφικές παραπομπές και ευρετήριο
|
| 650 |
|
0 |
|a HIV infections
|
| 650 |
|
0 |
|a HIV (Viruses)
|
| 710 |
|
|
|a International Agency for Research on Cancer
|
| 710 |
|
|
|a World Health Organization
|
| 710 |
2 |
|
|a International Agency for Research on Cancer
|
| 952 |
|
|
|a GR-KoDPT
|b 59cc237c6c5ad13446f8ffcf
|c 998a
|d 945l
|e WC 140
|t 1
|x m
|z Books
|
